PortfoliosLab logoPortfoliosLab logo
TMHC vs. LLY
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

TMHC vs. LLY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Taylor Morrison Home Corporation (TMHC) and Eli Lilly and Company (LLY). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, TMHC achieves a 22.13% return, which is significantly higher than LLY's 5.78% return. Over the past 10 years, TMHC has underperformed LLY with an annualized return of 17.21%, while LLY has yielded a comparatively higher 33.45% annualized return.


TMHC

1D
-0.01%
1M
26.25%
YTD
22.13%
6M
14.86%
1Y
23.90%
3Y*
15.27%
5Y*
20.87%
10Y*
17.21%

LLY

1D
-2.41%
1M
12.74%
YTD
5.78%
6M
10.64%
1Y
39.26%
3Y*
37.45%
5Y*
39.59%
10Y*
33.45%
*Multi-year figures are annualized to reflect compound growth (CAGR)

TMHC vs. LLY - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
TMHC
Taylor Morrison Home Corporation
22.13%-3.82%14.73%75.78%-13.19%36.30%17.34%37.48%-35.02%27.05%
LLY
Eli Lilly and Company
5.78%40.25%33.30%60.91%34.26%66.08%31.04%16.14%40.45%17.83%

Correlation

The correlation between TMHC and LLY is 0.12, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.12

Correlation (3Y)
Calculated over the trailing 3-year period

0.18

Correlation (5Y)
Calculated over the trailing 5-year period

0.18

Correlation (10Y)
Calculated over the trailing 10-year period

0.16

Correlation (All Time)
Calculated using the full available price history since Apr 10, 2013

0.18

Fundamentals

Market Cap

TMHC:

$7.01B

LLY:

$1.02T

EPS

TMHC:

$6.75

LLY:

$28.14

PE Ratio

TMHC:

10.65

LLY:

40.26

PEG Ratio

TMHC:

0.66

LLY:

0.81

PS Ratio

TMHC:

0.94

LLY:

14.08

PB Ratio

TMHC:

1.12

LLY:

32.54

Total Revenue (TTM)

TMHC:

$7.61B

LLY:

$72.25B

Gross Profit (TTM)

TMHC:

$1.71B

LLY:

$59.75B

EBITDA (TTM)

TMHC:

$1.00B

LLY:

$32.97B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

TMHC vs. LLY — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

TMHC
TMHC Risk / Return Rank: 6161
Overall Rank
TMHC Sharpe Ratio Rank: 6161
Sharpe Ratio Rank
TMHC Sortino Ratio Rank: 6363
Sortino Ratio Rank
TMHC Omega Ratio Rank: 5959
Omega Ratio Rank
TMHC Calmar Ratio Rank: 6262
Calmar Ratio Rank
TMHC Martin Ratio Rank: 5959
Martin Ratio Rank

LLY
LLY Risk / Return Rank: 7373
Overall Rank
LLY Sharpe Ratio Rank: 7575
Sharpe Ratio Rank
LLY Sortino Ratio Rank: 7070
Sortino Ratio Rank
LLY Omega Ratio Rank: 7171
Omega Ratio Rank
LLY Calmar Ratio Rank: 7474
Calmar Ratio Rank
LLY Martin Ratio Rank: 7575
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

TMHC vs. LLY - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Taylor Morrison Home Corporation (TMHC) and Eli Lilly and Company (LLY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


TMHCLLYDifference
Sharpe ratioReturn per unit of total volatility

-0.53

Sortino ratioReturn per unit of downside risk

-0.31

Omega ratioGain probability vs. loss probability

1.15

1.22

-0.07

Calmar ratioReturn relative to maximum drawdown

0.89

1.72

-0.83

Martin ratioReturn relative to average drawdown

1.66

4.28

-2.62

TMHC vs. LLY - Sharpe Ratio Comparison

The current TMHC Sharpe Ratio is 0.54, which is lower than the LLY Sharpe Ratio of 1.07. The chart below compares the historical Sharpe Ratios of TMHC and LLY, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

TMHC vs. LLY - Drawdown Comparison

The maximum TMHC drawdown since its inception was -75.18%, which is greater than LLY's maximum drawdown of -68.24%. Use the drawdown chart below to compare losses from any high point for TMHC and LLY.


Loading charts...

Drawdown Indicators


TMHCLLYDifference

Max Drawdown

Largest peak-to-trough decline

-75.18%

-68.24%

-6.94%

Max Drawdown (1Y)

Largest decline over 1 year

-23.80%

-23.64%

-0.16%

Max Drawdown (3Y)

Largest decline over 3 years

-27.90%

-34.48%

+6.58%

Max Drawdown (5Y)

Largest decline over 5 years

-40.84%

-34.48%

-6.36%

Max Drawdown (10Y)

Largest decline over 10 years

-75.18%

-34.48%

-40.70%

Current Drawdown

Current decline from peak

-3.88%

-2.41%

-1.47%

Average Drawdown

Average peak-to-trough decline

-20.26%

-19.21%

-1.05%

Ulcer Index

Depth and duration of drawdowns from previous peaks

12.79%

9.49%

+3.30%

Volatility

TMHC vs. LLY - Volatility Comparison

Taylor Morrison Home Corporation (TMHC) has a higher volatility of 21.03% compared to Eli Lilly and Company (LLY) at 9.27%. This indicates that TMHC's price experiences larger fluctuations and is considered to be riskier than LLY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


TMHCLLYDifference

Volatility (1M)

Calculated over the trailing 1-month period

21.03%

9.27%

+11.76%

Volatility (6M)

Calculated over the trailing 6-month period

29.55%

27.16%

+2.39%

Volatility (1Y)

Calculated over the trailing 1-year period

39.09%

38.01%

+1.08%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

37.83%

32.46%

+5.37%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

44.77%

30.19%

+14.58%

Dividends

TMHC vs. LLY - Dividend Comparison

TMHC has not paid dividends to shareholders, while LLY's dividend yield for the trailing twelve months is around 0.57%.


PositionTTM20252024202320222021202020192018201720162015
LLY
Eli Lilly and Company
0.57%0.56%0.67%0.78%1.07%1.23%1.75%1.96%1.94%2.46%2.77%2.37%
TMHC
Taylor Morrison Home Corporation
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

TMHC vs. LLY - Financials Comparison

This section allows you to compare key financial metrics between Taylor Morrison Home Corporation and Eli Lilly and Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.005.00B10.00B15.00B20.00B20222023202420252026
1.39B
19.80B
(TMHC) Total Revenue
(LLY) Total Revenue
Values in USD except per share items

TMHC vs. LLY - Profitability Comparison

The chart below illustrates the profitability comparison between Taylor Morrison Home Corporation and Eli Lilly and Company over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

20.0%40.0%60.0%80.0%20222023202420252026
21.0%
79.0%
Portfolio components
TMHC - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Taylor Morrison Home Corporation reported a gross profit of 290.64M and revenue of 1.39B. Therefore, the gross margin over that period was 21.0%.

LLY - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Eli Lilly and Company reported a gross profit of 15.64B and revenue of 19.80B. Therefore, the gross margin over that period was 79.0%.

TMHC - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Taylor Morrison Home Corporation reported an operating income of 141.79M and revenue of 1.39B, resulting in an operating margin of 10.2%.

LLY - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Eli Lilly and Company reported an operating income of 9.19B and revenue of 19.80B, resulting in an operating margin of 46.4%.

TMHC - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Taylor Morrison Home Corporation reported a net income of 100.43M and revenue of 1.39B, resulting in a net margin of 7.2%.

LLY - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Eli Lilly and Company reported a net income of 7.40B and revenue of 19.80B, resulting in a net margin of 37.4%.


Frequently Asked Questions


TMHC and LLY have a correlation of 0.12, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

TMHC has higher volatility (21.03%) compared to LLY (9.27%). In terms of maximum drawdown, TMHC dropped -75.18% vs LLY's -68.24%.

LLY currently has the higher Sharpe Ratio (1.07 vs 0.54), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for TMHC and LLY

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer